SkinBioTherapeutics (SBTX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

15.88p
   
  • Change Today:
    -0.38p
  • 52 Week High: 19.50p
  • 52 Week Low: 7.25p
  • Currency: UK Pounds
  • Shares Issued: 228.44m
  • Volume: 615,738
  • Market Cap: £36.26m
  • Beta: 1.22

Regulatory News

Finalisation of commercial agreement with Croda 19-Nov-2024 07:00 RNS
Holding(s) in Company 25-Oct-2024 16:29 RNS
Integration update and share price movement 23-Oct-2024 14:40 RNS
Holding(s) in Company 17-Oct-2024 07:00 RNS
Issue of Equity and Total Voting Rights 16-Oct-2024 07:00 RNS
Acquisition and Financial Update 11-Oct-2024 07:00 RNS
Notice of Investor Meet Company Presentation 04-Oct-2024 14:02 RNS
Final testing of SkinBiotix by Croda completed 19-Sep-2024 07:00 RNS
Holding(s) in Company 13-Aug-2024 12:49 RNS
Holding(s) in Company 08-Aug-2024 07:00 RNS
Investment of £1.56m from new investors 02-Aug-2024 07:00 RNS
Appointment of Senior Croda VP as Board Advisor 29-Jul-2024 07:01 RNS
Full year trading update 29-Jul-2024 07:00 RNS
Closure of Convertible Bond Facility 23-Jul-2024 07:00 RNS
Conversion Notice and Total Voting Rights 22-Jul-2024 07:00 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

SBTX Market Data

Currency UK Pounds
Share Price 15.88p
Change Today -0.38p
% Change -2.31 %
52 Week High 19.50p
52 Week Low 7.25p
Volume 615,738
Shares Issued 228.44m
Market Cap £36.26m
Beta 1.22

SBTX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
72.99% below the market average72.99% below the market average72.99% below the market average72.99% below the market average72.99% below the market average
96% below the sector average96% below the sector average96% below the sector average96% below the sector average96% below the sector average
Price Trend
1.45% above the market average1.45% above the market average1.45% above the market average1.45% above the market average1.45% above the market average
51.02% above the sector average51.02% above the sector average51.02% above the sector average51.02% above the sector average51.02% above the sector average
Income Not Available
Growth
21.88% above the market average21.88% above the market average21.88% above the market average21.88% above the market average21.88% above the market average
11.76% above the sector average11.76% above the sector average11.76% above the sector average11.76% above the sector average11.76% above the sector average

SBTX Dividends

No dividends found

Trades for 21-Nov-2024

Time Volume / Share Price
15:51 7,500 @ 15.95p
14:41 100,000 @ 15.75p
14:39 100,000 @ 15.75p
15:10 6 @ 15.50p
15:10 187 @ 16.00p

SBTX Key Personnel

CEO Stuart Ashman
CFO Manprit Singh Randhawa

Top of Page